30 April 2017

Kenya - Sexually active young women and girls aged 15 to 24 are among the high-risk groups targeted in the May 4 rollout of a new method meant to protect HIV-negative people from contracting the virus. The approach, known as pre-exposure prophylaxis (PrEP), involves people at high risk of contracting HIV taking an antiretroviral pill, Truvada, daily to lower their chances of getting infected.

Read the full article online here.